# Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

> **NCT00109941** · PHASE2 · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** opioid growth factor
- **BIOLOGICAL:** metenkephalin, OGF-opioid growth factor

## Key facts

- **NCT ID:** NCT00109941
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10
- **Primary completion:** 2007-09
- **Final completion:** 2009-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109941, "Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00109941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*